Your session is about to expire
← Back to Search
Vitamin
NR plus Walking Exercise for High Blood Pressure
Phase 1
Waitlist Available
Led By Robert Mankowski, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; week 3; week 6
Awards & highlights
Study Summary
This trial suggests that nicotinamide riboside may help hypertensive older adults by enhancing the effects of exercise therapy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline; week 3; week 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; week 3; week 6
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in SBP
Secondary outcome measures
Arterial Stiffness
Trial Design
3Treatment groups
Active Control
Group I: NR plus Walking ExerciseActive Control2 Interventions
1,000 mg/day of NR combined with three days/week of supervised, center-based walking exercise (n=18)
Group II: NR AloneActive Control1 Intervention
1,000 mg/day of NR
Group III: Walking Exercise plus PlaceboActive Control1 Intervention
1,000 mg/day of Placebo combined with three days/week of supervised, center-based walking exercise (n=18)
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,692 Previous Clinical Trials
28,027,165 Total Patients Enrolled
University of FloridaLead Sponsor
1,350 Previous Clinical Trials
719,911 Total Patients Enrolled
Robert Mankowski, PhDPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
40 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger